Bosnia and Herzegovina vs Italy: Proportion of bloodstream infection due to methicillin-resistant
Bosnia and Herzegovina
28.4%
in 2023
Italy
29.5%
in 2023
Bosnia and Herzegovina rank
28th
Italy rank
26th
Proportion of bloodstream infection due to methicillin-resistant over time
- Bosnia and Herzegovina
- Italy
How they compare
Italy currently reports 29.5% against 28.4% in Bosnia and Herzegovina, a difference of 1.1%.
Across all 6 years both countries report, Italy has been ahead every year.
Bosnia and Herzegovina ranks 28th and Italy ranks 26th of 55 countries.
Italy has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Italy | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 13.4% | 36.4% | 22.9% | Italy |
| 2020s | 24.8% | 31.9% | 7.1% | Italy |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of bloodstream infection due to methicillin-resistant, Bosnia and Herzegovina or Italy?
- Italy, at 29.5% against 28.4% in Bosnia and Herzegovina as of 2023.
- What is the difference in proportion of bloodstream infection due to methicillin-resistant between Bosnia and Herzegovina and Italy?
- 1.1%, with Italy ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Italy?
- 6 years are reported by both, from 2018 to 2023.
- How do Bosnia and Herzegovina and Italy rank globally for proportion of bloodstream infection due to methicillin-resistant?
- Bosnia and Herzegovina ranks 28th and Italy ranks 26th of 55 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.